NR4A2 and Parkinson disease: Additionally, these compounds significantly improved behavioral deficits in 6‐OHDA lesioned rat model of PD without any detectable signs of dyskinesia‐like behavior (Kim et al., 2015), underscoring the potential of small molecules targeting Nurr1 as neuroprotective strategy for PD (Kim et al., 2015).